Several non-␤-lactam compounds were active against various gram-positive and gram-negative bacterial strains. The MICs of arylalkylidene rhodanines and arylalkylidene iminothiazolidin-4-ones were lower than those of ampicillin and cefotaxime for methicillin-resistant Staphylococcus aureus MI339 and vancomycinresistant Enterococcus faecium EF12. Several compounds were found to inhibit the cell wall synthesis of S. aureus and the last two steps of peptidoglycan biosynthesis catalyzed by ether-treated cells of Escherichia coli or cell wall membrane preparations of Bacillus megaterium. The effects of the arylalkylidene rhodanines and arylalkylidene iminothiazolidin-4-one derivatives on E. coli PBP 3 and PBP 5, Streptococcus pneumoniae PBP 2xS (PBP 2x from a penicillin-sensitive strain) and PBP 2xR (PBP 2x from a penicillin-resistant strain), low-affinity PBP 2a of S. aureus, and the Actinomadura sp. strain R39 and Streptomyces sp. strain R61 DDpeptidases were studied. Some of the compounds exhibited inhibitory activities in the 10 to 100 M concentration range. The inhibition of PBP 2xS by several of them appeared to be noncompetitive. The dissociation constant for the best inhibitor (K i ‫؍‬ 10 M) was not influenced by the presence of the substrate.
The emergence of bacterial strains resistant to present antibiotics highlights the need for new antibacterial compounds (4, 12, 17) . The last two steps of peptidoglycan biosynthesis are particularly attractive targets for potential antibacterial compounds since they take place on the external surface of the cytoplasmic membrane and are therefore readily accessible and peptidoglycan is specific to prokaryotic cells. Moenomycin (5) , a competitive inhibitor of the transglycosylation reaction, and inactivators of the transpeptidation reaction (␤-lactam antibiotics) (12, 13) have been studied in detail over the years. Furthermore, several enzymes of this biosynthetic pathway have been isolated and described. These have mainly been the DD-transpeptidases, also called penicillin-binding proteins (PBPs), which catalyze the last step of peptidoglycan biosynthesis (13) .
Several PBPs from Escherichia coli have been isolated, and their roles in peptidoglycan biosynthesis and cell division have been investigated. Among the high-molecular mass PBPs from E. coli, bifunctional enzymes such as PBP 1b exhibit both transglycosylase and transpeptidase activities (29) , while monofunctional enzymes such as PBP 3 (2, 3, 18) behave only as transpeptidases. The low-molecular mass PBPs, such as PBP 4 and PBP 5 (31) as well as PBP 6 (13) , are responsible for most of the carboxypeptidase activity. These enzymes appear to be involved in maintaining the correct balance between the various precursors in such a way that cells can elongate or divide.
Bacterial strains have developed different strategies to escape the lethal actions of antibiotics. The targets can be modified in a way that allows them to retain their physiological activity but decreases their sensitivity to the aggressor. Various intrinsic penicillin-resistant strains have thus been isolated (22, 27) . Another possibility is the protection afforded by efficient permeability barriers or the destruction of the antibiotics. Many ␤-lactamases have been isolated in the past, and new enzymes which are responsible for important clinical problems are continuously detected (26) . Although class A ␤-lactamases can be inactivated by clavulanic acid, sulbactam, and tazobactam, no efficient inhibitors of the members of the three other classes (classes B, C, and D) are available. Recently, the inhibition of class C ␤-lactamases by rhodanines similar to those used in this study has been described (19) . In the present work, we have shown that several non-␤-lactam compounds, arylalkylidene rhodanines and arylalkylidene iminothiazolidin-4-ones ( Fig. 1 ), can interfere with bacterial growth. Their effects on peptidoglycan biosynthesis in vitro and on the activities of several DD-peptidases and PBPs were studied.
Enzymes. PBP 2xS (PBP 2x from a penicillin-sensitive strain of Streptococcus pneumoniae) and PBP 2xR (PBP 2x from a penicillin-resistant strain of S. pneumoniae) were purified previously (20, 25) . PBP 3 from E. coli was given to us by C. Fraipont (University of Liège). PBP 5 from E. coli was a gift from J.-M. Wilkin. The R61 and R39 DD-peptidases were purified as described by Granier et al. (18) .
Testing of antibacterial activities. Bacterial strains were obtained from the American Type Culture Collection (Manassas, Va.) or were recent clinical isolates. MICs were determined as follows: twofold serial dilutions of the test compounds were prepared in 100 l of cation-adjusted Mueller-Hinton broth in each well of 96-well microtiter plates. Bacterial inocula of ϳ5 ϫ 10 5 CFU/ml were delivered to each well. Organisms were incubated at 37°C for 20 to 24 h before visual determination of the end point of no bacterial growth in the wells.
Cell wall synthesis assay. Cell wall synthesis was tested by monitoring the incorporation of [ 3 H]glycine into the cell wall of Staphylococcus aureus. The test compounds were diluted in cation-adjusted Mueller-Hinton broth as 10-point dose-response curves in 96-well microtiter plates. A penicillin-sensitive strain of S. aureus (strain Mi246) was grown to an A 600 of 0.05 to 0.08, and the cells were then treated with tetracycline to block protein biosynthesis. Subsequently, this cell suspension was added to 96-well microtiter plates containing serial dilutions of the test compounds. The S. aureus cells were incubated in the presence of inhibitors and [
3 H]glycine for 30 min at 37°C. The cell wall synthesis reaction was stopped by the addition of 15% trichloroacetic acid, which caused lysis of the cells and precipitation of the cellular macromolecules. Unbound radiolabel was removed by filtering and subsequent washing of the filter plates twice with 5% trichloroacetic acid and once with 100% ethanol. Scintillant was then added to each well and the plates were subjected to scintillation counting on a Packard Topcount counter. The raw counts per minute data were then imported into an Excel spreadsheet for analysis. Percent inhibition values were calculated by comparing the counts per minute of the wells with the test compounds to the average counts per minute for the negative control (0% inhibition) and the background control. Regression analysis was used to calculate the concentration at which cell wall synthesis was inhibited by 50% (IC 50 ).
Inhibition of peptidoglycan biosynthesis. The inhibition of peptidoglycan biosynthesis was determined by starting with the synthesis of the lipid intermediates from UDP-MurNAc-pentapeptide and UDP-GlcNAc (Fig. 2) . For the in vitro experiments, Bacillus megaterium membranes and ether-treated E. coli cells were used as the enzyme sources and undecaprenol phosphate was used as the substrate.
(i) In vitro experiments with B. megaterium membranes. B. megaterium was grown at 37°C to an A 600 of 1.2 in 250 ml of medium, and the cells were harvested and washed as described by Broetz et al. (7) . The cells were resuspended in 15 ml of 50 mM Tris-HCl buffer (pH 7.8) containing 10 mM MgCl 2 . The resuspended cells were broken with 15 ml of glass beads (diameter, 0.1 mm) in a BeadBeater (Biospec Products Inc.). The cells were broken five times for 30 s each time on ice. The runs were performed at 1-min intervals in order to cool the solution. After the disruption the glass beads were washed twice with 5 ml of buffer. The membranes were separated from the buffer by centrifugation (6,000 ϫ g, 10 min, 4°C). The pellet was washed with 7 ml of buffer, and the final precipitate was resuspended in 2 ml of buffer. A protein concentration of 0.8 mg/ml was detected, as determined by the method described by Bradford (6) .
Membrane suspensions (20 l) were incubated in the presence of 0.4 mM UDP-MurNAc-pentapeptide and 0.4 M UDP-GlcNAc (2 Ci/mol) in 50 mM Tris-HCl (pH 7.8)-10 mM MgCl 2 at 25°C for 1.5 h (total volume, 30 l), as described by Broetz et al. (7) . In the inhibition experiments antibiotics were added at a concentration of 100 g/ml. The reaction was stopped by heating the sample to 100°C for 1 min. The substrates and the reaction products were separated by paper chromatography, as described by Terrak et al. (29) . A total of 20 l of the assay solution was deposited on the paper. A Bio-Rad FX molecular imager was used for detection.
(ii) In vitro experiments with ether-treated E. coli cells. E. coli DH5␣ was grown in 250 ml of Luria-Bertani medium at 37°C to an A 600 of 0.7. Etherpermeabilized E. coli cells were prepared as described by Vosberg and Hoffmann-Berling (30) . A 7.2-ml suspension of ether-permeabilized E. coli cells was stored at Ϫ20°C.
A total of 40 l of the ether-permeabilized E. coli cells was incubated at 30°C with 0.05 mM UDP-MurNAc-pentapeptide and 0.05 M UDP-GlcNAc (2 Ci/ mol) in 50 mM Tris-HCl (pH 8.3)-MgCl 2 -50 mM NH 4 Cl-5% dimethyl sulfoxide-0.5 mM mercaptoethanol, as described by Ge et al. (17) . In the inhibition experiments the antibiotics were added at concentrations of 100 g/ml. The reaction was stopped by centrifugation (4,500 ϫ g, Eppendorf centrifuge, 8 min). The pellet was resuspended in 20 l of 4% sodium dodecyl sulfate and heated at 100°C for 15 min. A total of 20 l of the suspension was deposited on the paper, and paper chromatography was performed as described above. Inhibition of S. pneumoniae PBP 2xR. The inhibitors were studied in a competition experiment with Flu-AMP, whose properties have been described by Lakaye et al. (23) . The assay system was that of Galleni et al. (16) . The enzyme and the substrate concentrations were chosen so that the time course of PBP labeling by Flu-AMP was linear, and the decrease in the rate of labeling was determined with increasing concentrations of inhibitors. A control experiment was performed with benzylpenicillin.
The accumulation of labeled protein was linear for about 20 min when 0.8 M PBP 2xR and 10 M Flu-AMP were incubated at 37°C in 10 mM Tris-HCl with 100 mM NaCl (pH 7.5). In the inhibition experiments the inhibitor concentrations were in the 1 to 100 M range.
The reaction was stopped by the addition of 12.5 l of denaturation buffer, as described by Galleni et al. (16) , and the sample was heated at 100°C for 1 min. A total of 20 l of the assay mixture was loaded onto a 12% acrylamide-sodium dodecyl sulfate gel (9 by 7 cm). A Bio-Rad FX molecular imager was used for detection.
Inhibition of S. pneumoniae PBP 2xS. The residual activity of 0.2 M PBP 2xS was determined after preincubation for 20 min at 37°C in the presence of 20 or 50 M inhibitor in 10 mM sodium phosphate (pH 7.0). The initial rate of hydrolysis of 1 mM S2d thiolester in the presence of 2 mM 4,4Ј-dithiodipyridine was determined by monitoring the increase in the absorbance at 324 nm (change in ε [⌬ε] ϭ 20,000 M Ϫ1 cm Ϫ1 ) (Fig. 3) . The rate of spontaneous hydrolysis of S2d was also determined in the absence of the enzyme.
The inhibition of PBP 2xS by arylalkylidene rhodanine derivatives 2 and 3, arylalkylidene iminothiazolidin-4-one derivative 6, and cephalexin was studied directly by the reporter substrate method in the presence of the S2c thiolester. The first-order rate constant (k i ) was determined in the presence of different substrate concentrations and a fixed inhibitor concentration. The spontaneous hydrolysis of the substrate was linear for up to 30 min and had no influence on the k i value. In all cases the level of substrate utilization was less than 10%. The rate of 0.32 M PBP 2xS inactivation was measured at 37°C in 10 mM sodium phosphate (pH 7.0) in the presence of 1.2 mM 4,4Ј-dithiodipyridine and different concentrations of S2c. The increase in the absorbance at 324 nm was measured with a Uvikon 860 spectrometer connected to a microcomputer, and the kinetic parameters were computed by analyzing the complete time courses (10) .
Steady-state rates of hydrolysis (v ss ) were also measured with arylalkylidene rhodanine derivative 2. The time courses of S2c hydrolysis, as shown in Fig. 4 , were characterized by a burst followed by the steady state after about 20 min. 
where S is the substrate concentration, K i is the dissociation constant of EI and K i Ј is that of ESI, and I is the inhibitor concentration, and the program GRAFIT.
Inhibition of E. coli Table 1 . Furthermore, no activity against S. pneumoniae ATCC 6301 or E. coli ATCC 25922 was observed. The compounds were active against MRSA MI339 and VRE EF12, but some compounds had only a low level of activity against PRSP STP51. In contrast, ampicillin and cefotaxime were quite active against penicillin-resistant S. pneumoniae, while the ampicillin and cefotaxime MICs for the other resistant strains, MRSA MI339 and E. faecium EF12 (VRE), were high: 92 and Ͼ200 M, respectively. In particular, the MICs of arylalkylidene rhodanine derivative 1 were lower than those of ampicillin for several strains.
Effects on peptidoglycan synthesis in vitro.
The effects of the compounds on cell wall synthesis were investigated by monitoring the level of [ 3 H]glycine incorporation into the cell wall of a penicillin-sensitive S. aureus strain. The IC 50 s (Table 2) showed that cell wall synthesis was inhibited in the presence of these compounds. Furthermore, the effects of the compounds on peptidoglycan biosynthesis by B. megaterium and E. coli were studied. In vitro cell wall membrane preparations from B. megaterium and ether-treated E. coli cells catalyze the synthesis of cross-linked peptidoglycan from soluble UDP-linked cytoplasmic precursors (UDP-GlcNAc and UDP-MurNAcpentapeptide). By using UDP-[ 14 C]GlcNAc, the assay permits the following enzymatic reactions to be distinguished: (i) the S. pneumoniae ATCC 6301 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 0.2 Յ0.1 S. pneumoniae STP51 (PRSP) Ͼ200 Ͼ200 Ͼ200 Ͼ200 128 37 Ͼ200 32 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 110 140 Ͼ200 Ͼ200 E. coli ATCC 25922 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 Ͼ200 (Fig. 2) . At Ϫ20°C the cell wall membrane preparations of B. megaterium exhibiting a specific activity of 1.2 nmol/ mg/min were stable for 1 month and the ether-treated E. coli cells were stable for several months. The effects of various inhibitors on in vitro synthesis with cell wall membrane preparations of B. megaterium are shown in Table 3 , and the effects of various inhibitors on in vitro synthesis with ether-treated E. coli cells are shown in Fig. 5 . In the presence of tunicamycin (100 g/ml), an inhibitor of lipid I biosynthesis, no lipid II or peptidoglycan was formed (Table 3) . With increasing concentrations of vancomycin, which inhibits the glycosyltransferase activity by complexing the D-Ala-D-Ala of lipid II, increased levels of inhibition of peptidoglycan biosynthesis by ethertreated E. coli cells was observed (Fig. 5) , while in the presence of cefoxitin (100 g/ml), an inhibitor of the transpeptidase, the amount of peptidoglycan synthesized by ether-treated E. coli cells decreased to 77% (absolute error, 15%). These results are in agreement with previous observations (7, 17) . In the presence of our compounds no inhibition of the synthesis of lipid II was observed, so that an interaction between these compounds and translocase I and MurG could be excluded. In vitro they behaved as inhibitors of the synthesis of polymeric strands of gram-positive and gram-negative bacteria. In vivo no influence on E. coli cells was observed. Therefore, the compounds tested probably cannot permeate the outer membrane of E. coli. Effects on PBPs. The formation of mature peptidoglycan is catalyzed by PBPs, which cross-link the nascent chains via peptide bonds. The effects of the inhibitors on different PBPs from different species were studied. PBP 3 (2, 3, 18) and PBP 5 (31) from E. coli have different roles in vivo. High-molecularmass PBP 3 appears to act as a transpeptidase and exhibits a thiolesterase activity. A similar thiolesterase activity is observed with low-molecular-mass PBP 5, which also acts as a DD-carboxypeptidase with peptide substrates. It is possible to directly monitor the hydrolysis of the thiolester substrates by UV spectrophotometry. Table 4 shows the residual activities against thiolester S2d. The effects of various potential inhibitors were studied by measuring the residual hydrolytic activities against thiolester S2d after 20 min of incubation with the compounds (Fig. 3) .
Some inhibitors exhibited residual activities lower than 20% in the presence of 50 M inhibitor and residual activities higher than 80% with 20 M inhibitor. Even with an absolute error of 10%, the decrease in residual activities between 20 and 50 M seems to be too high for some inhibitors. Furthermore, an unexpected increase in the k i of PBP 2xS in the presence of high concentrations of inhibitor 2 was observed. The unexpected behaviors of some inhibitors could be the result of a cooperative effect. The inhibition of PBP 5 with compounds 2 and 13 was time dependent.
The role of PBP 2 in S. pneumoniae is still unknown (20) . The enzyme exhibits esterase and thiolesterase activities in vitro. As described above, the thiolesterase activity of PBP 2xS was used to determine the residual activity after preincubation of the enzyme with different inhibitors (Table 4) . The thiolesterase activity of PBP 2xR (21, 25) , which was from S. pneumoniae clinical isolate C(S109), was too low to allow easy screening. PBP 2xR was studied in a competition experiment with Flu-AMP. The enzyme and substrate concentrations and the incubation time were optimized in order to find assay conditions that resulted in a linear time course of the labeling Tables 4 and 5 show that both enzymes were inhibited in the presence of compounds 2, 4, and 13. In assays with whole cells, no activities against S. pneumoniae ATCC 6301 or only low levels of activity of some compounds were observed against PRSP strain STP51. The absence of activity in the whole-cell assay was probably the result of the a The residual activities of PBP 2xR, PBP 5, and PBP 3 were determined by monitoring the v i,0 of the S2d thiolester in the presence of 50 M inhibitor after a 20-min preincubation. The DD-peptidase activities of R61 and R39 were used to determine the residual acitivities of these enzymes in the presence of 50 M inhibitor. The activity in the absence of the inhibitors was 100%. The absolute error was 10% for all experiments.
b ND, not determined.
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on August 28, 2017 by guest http://aac.asm.org/ interaction of these hydrophobic compounds with plasma proteins from the lysed horse blood used in the assay, as described by Roychoudhury et al. (28) . Low-affinity PBP 2a from S. aureus is responsible for ␤-lactam antibiotic resistance in staphylococci (8) . Recombinant PBP 2a was used to determine the IC 50 s of the different compounds in a competitive binding assay with [ 3 H]penicillin G as the reporter substrate. PBP 2a was inhibited by the compounds tested (Table 2 ). This result was compatible with those of the whole-cell assay, indicating that the compounds have high levels of activity against MRSA MI339.
The soluble, extracellular PBPs from Streptomyces sp. strain R61 (11, 15) and Actinomadura sp. strain R39 (14) have DDpeptidase, esterase, and thiolesterase activities. The DD-peptidase activity was used to determine the residual activity of the enzyme after preincubation with the various compounds. The results in Table 4 show that significant inhibition of both enzymes was observed only in the presence of arylalkylidene rhodanine derivative 2. In conclusion, several inhibitors of PBPs have been identified. Arylalkylidene rhodanine derivative 2 inhibited all PBPs and DD-peptidases tested.
Characterization of interaction between some inhibitors and PBP 2xS by kinetic studies. The inhibition of PBP 2xS by arylalkylidene rhodanine derivatives 2 and 3 and arylalkylidene iminothiazolidin-4-one derivative 6 was studied in detail in the presence of the thiolester S2c. Thiolester S2c is not the best substrate of PBP 2xS, but it is possible to measure initial rates near the K m value and up to 10 times the K m value. The following values have been determined by Jamin et al. (20) : Figure 6 shows the enzymatic activity and the spontaneous hydrolysis of S2c in the presence and absence of PBP 2xS, respectively. In the enzymatic reaction, the k cat value of 0.2 Ϯ 0.01 s Ϫ1 and the K m value of 0.18 Ϯ 0.03 mM were found to be in good agreement with the values of Jamin et al. (20) . The inhibition of PBP 2xS was time dependent (Fig. 7) . For the slowly binding inhibitors the relationship between k i and the substrate concentration with fixed inhibitor concentrations is characteristic of the interaction between the inhibitor and the enzyme (9) . The spontaneous hydrolysis of the substrate is linear for up to 30 min and has no influence on the k i value. Cephalexin, a cephalosporin, has a k cat /K m value of 1,600 M Ϫ1 s Ϫ1 . The rate of inhibition by 10 M cephalexin was slow, so it was possible to investigate the reaction in the presence of S2c as the reporter substrate under the same conditions used with compounds 2, 3, and 6. a slow to very slow reactivation phenomenon was observed with the ␤-lactams.
In conclusion, cephalexin, a ␤-lactam compound and an active site-directed inactivator of PBPs (11) , forms an acyl enzyme with the serine residue in the active site (13) . In contrast, arylalkylidene rhodanine derivative 2 behaves as a noncompetitive inhibitor of PBP 2xS and probably does not interact with the active site of this enzyme. Since some of the results might be explained by nonspecific interactions of the hydrophobic molecules with a variety of targets, further experiments are needed to identify the site of interaction and clarify the mechanism of inhibition of PBP 2xS. Furthermore, the inhibition of the other DD-peptidases and PBPs should be studied.
